A banner year for Berkeley, CA-based Aduro just got better. The biotech has inked its second licensing pact of the year with Johnson & Johnson, which kicked in a $30 million upfront and boosted its total milestone package to the $1 billion-plus category.

…read more

Source: J&J adds an $817M cancer drug pact with ambitious Aduro


0 No comments